Another study conducted on DN of a type 2 diabetes rat model reported that bone marrow-derived MSCs induced a significant inhibition of renal fibrosis, which was involved in inhibiting the TGF-beta 1/Smad3 pathway and decreasing plasminogen activator inhibitor-1 [62]. The gene discussed is TGFB1; the disease is renal fibrosis.